Jeff Glazier
Chief Executive Officer
A founding member of General Oncology, Jeff has been Chief Executive Officer since August 2024 and was previously Chief Operating Officer since 2019. In both roles, he has been responsible for all business decisions of General Oncology. He determined corporate strategy, vetted and selected clinical trial sites, managed all non-medical aspects of the SHARON Trial, selected laboratories for preclinical work, carried out all clinical trial tasks that would typically be performed by a contract research organization other than medical monitoring and clinical data monitoring, performed the function of an in-house legal counsel for all corporate and research matters, selected and maintained the IT infrastructure, and played a pivotal role in securing the company’s patents. Prior to General Oncology, he was a co-founder of the health-care technology company ProviderTech LLC and a private equity attorney at Ropes & Gray LLP. He holds a J.D. from Harvard Law School and an Sc.B. in neuroscience from Brown University.